{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:04:46Z","timestamp":1794654286170,"version":"4.9.1"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cell loss and mitochondrial dysfunction are key pathological features of idiopathic Parkinson\u2019s disease (PD) and multiple system atrophy (MSA). It remains unclear whether disease-specific changes in plasma circulating cell-free nuclear DNA (cf-nDNA) and mitochondrial DNA (cf-mtDNA) occur in patients with PD and MSA. In this study, we investigated whether plasma cf-nDNA, cf-mtDNA levels, as well as cf-mtDNA integrity, are altered in patients with PD and MSA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>TaqMan probe-based quantitative PCR was employed to measure plasma cf-nDNA levels, cf-mtDNA copy numbers, and cf-mtDNA deletion levels in 171 participants, including 76 normal controls (NC), 62 PD patients, and 33 MSA patients. A generalized linear model was constructed to analyze differences in circulating cell-free DNA (cfDNA) biomarkers across clinical groups, while a logistic regression model was applied to assess the predictive values of these biomarkers for developing PD or MSA. Spearman correlations were used to explore associations between the three cfDNA biomarkers, demographic data, and clinical scales.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant differences in plasma cf-nDNA levels, cf-mtDNA copy numbers, or cf-mtDNA deletion levels were observed among the PD, MSA, and NC groups (all <jats:italic>P<\/jats:italic> &amp;gt; 0.05). Additionally, these measures were not associated with the risk of developing PD or MSA. In PD patients, cf-nDNA levels were positively correlated with Hamilton Anxiety Rating Scale scores (Rho = 0.382, FDR adjusted <jats:italic>P<\/jats:italic> = 0.027). In MSA patients, cf-nDNA levels were positively correlated with International Cooperative Ataxia Rating Scale scores (Rho = 0.588, FDR adjusted <jats:italic>P<\/jats:italic> = 0.011) and negatively correlated with Montreal Cognitive Assessment scores (Rho = \u22120.484, FDR adjusted <jats:italic>P<\/jats:italic> = 0.044). Subgroup analysis showed that PD patients with constipation had significantly lower plasma cf-mtDNA copy numbers than those without constipation (<jats:italic>P<\/jats:italic> = 0.049). MSA patients with cognitive impairment had significantly higher cf-nDNA levels compared to those without (<jats:italic>P<\/jats:italic> = 0.008).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma cf-nDNA level, cf-mtDNA copy number, and cf-mtDNA deletion level have limited roles as diagnostic biomarkers for PD and MSA. However, their correlations with clinical symptoms support the hypothesis that cell loss and mitochondrial dysfunction are involved in PD and MSA development.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2024.1488820","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:24:23Z","timestamp":1733120663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson\u2019s disease and multiple system atrophy"],"prefix":"10.3389","volume":"18","author":[{"given":"Chao","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songnian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22400-z","article-title":"Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson\u2019s disease and lewy body dementia.","volume":"12","author":"Asghar","year":"2022","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00439-004-1123-9","article-title":"Mitochondrial DNA polymorphisms as risk factors for Parkinson\u2019s disease and Parkinson\u2019s disease dementia.","volume":"115","author":"Autere","year":"2004","journal-title":"Hum. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"37206","DOI":"10.1074\/jbc.M112.369942","article-title":"Amyloid fibrils trigger the release of neutrophil extracellular traps (nets), causing fibril fragmentation by net-associated elastase.","volume":"287","author":"Azevedo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jnen\/nlw037","article-title":"Decreased coenzyme q10 levels in multiple system atrophy cerebellum.","volume":"75","author":"Barca","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0022-510x(94)90248-8","article-title":"Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson\u2019s disease and multiple system atrophy.","volume":"125","author":"Blin","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/brain\/awaa246","article-title":"Mitochondrial damage-associated inflammation highlights biomarkers in prkn\/pink1 Parkinsonism.","volume":"143","author":"Borsche","year":"2020","journal-title":"Brain"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092147","article-title":"New perspectives on the importance of cell-free DNA biology.","volume":"12","author":"Bronkhorst","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20209881","article-title":"Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders.","volume":"53","author":"Bruno","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.parkreldis.2005.01.008","article-title":"A definition of Parkinson\u2019s disease.","volume":"11","author":"Calne","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"G510","DOI":"10.1152\/ajpgi.90650.2008","article-title":"Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders.","volume":"296","author":"Camilleri","year":"2009","journal-title":"Am. J. Physiol. Gastroint. Liver Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5665\/sleep.4490","article-title":"White matter damage and systemic inflammation in obstructive sleep apnea.","volume":"38","author":"Chen","year":"2015","journal-title":"Sleep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7371403","article-title":"Plasma DNA mediate autonomic dysfunctions and white matter injuries in patients with Parkinson\u2019s disease.","volume":"2017","author":"Chen","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00009","article-title":"Associations among cognitive functions, plasma DNA, and white matter integrity in patients with early-onset parkinson\u2019s disease.","volume":"11","author":"Chen","year":"2017","journal-title":"Front. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1016\/j.bbadis.2018.09.018","article-title":"Mitochondrial dysfunction in fibroblasts of multiple system atrophy.","volume":"1864","author":"Compagnoni","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1212\/CPJ.0000000000000702","article-title":"Serum fgf-21, gdf-15, and blood mtDNA copy number are not biomarkers of Parkinson disease.","volume":"10","author":"Davis","year":"2020","journal-title":"Neurol. Clin. Pract."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838109","article-title":"Cell-free DNA promotes inflammation in patients with oral lichen planus via the sting pathway.","volume":"13","author":"Deng","year":"2022","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13548","article-title":"Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease.","volume":"7","author":"D\u00f6lle","year":"2016","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-023-02557-1","article-title":"Biomarkers for parkinsonian disorders in cns-originating evs: Promise and challenges.","volume":"145","author":"Dutta","year":"2023","journal-title":"Acta Neuropathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/JPD-160991","article-title":"The potential role of gut-derived inflammation in multiple system atrophy.","volume":"7","author":"Engen","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamapsychiatry.2013.4374","article-title":"Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.","volume":"71","author":"Eraly","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease.","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: Substantia nigra regional selectivity.","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1177\/1352458518786055","article-title":"Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.","volume":"25","author":"Fissolo","year":"2019","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02253","article-title":"Distinct autoimmune anti-\u03b1-synuclein antibody patterns in multiple system atrophy and Parkinson\u2019s disease.","volume":"10","author":"Folke","year":"2019","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101074","article-title":"Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.","volume":"4","author":"Fridlich","year":"2023","journal-title":"Cell Rep. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/brain\/awac438","article-title":"Cell-free DNA-based liquid biopsies in neurology.","volume":"146","author":"Gaitsch","year":"2023","journal-title":"Brain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy.","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jnr.24592","article-title":"DNA damage and repair in Parkinson\u2019s disease: Recent advances and new opportunities.","volume":"99","author":"Gonzalez-Hunt","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/mds.870120323","article-title":"Mitochondrial respiratory chain function in multiple system atrophy.","volume":"12","author":"Gu","year":"1997","journal-title":"Mov. Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tips.2008.03.007","article-title":"Parkinson\u2019s disease and pesticides: A toxicological perspective.","volume":"29","author":"Hatcher","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00702-016-1545-2","article-title":"Multiple system atrophy: Pathogenic mechanisms and biomarkers.","volume":"123","author":"Jellinger","year":"2016","journal-title":"J. Neural. Transm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.47936\/encephalitis.2023.00031","article-title":"Peripheral blood inflammatory cytokines in prodromal and overt alpha-synucleinopathies: A review of current evidence.","volume":"3","author":"Jun","year":"2023","journal-title":"Encephalitis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"E451","DOI":"10.1503\/jpn.200238","article-title":"Alterations of cellular aging markers in obsessive- compulsive disorder: Mitochondrial DNA copy number and telomere length.","volume":"46","author":"Kang","year":"2021","journal-title":"J. Psychiatry. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01182-7","article-title":"Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA.","volume":"13","author":"Kerachian","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.parkreldis.2008.04.001","article-title":"Frequency of psychiatric disorders in young-onset parkinson\u2019s disease does not differ from typical-onset Parkinson\u2019s disease.","volume":"15","author":"Kummer","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00954-y","article-title":"Brain alarm by self-extracellular nucleic acids: From neuroinflammation to neurodegeneration.","volume":"30","author":"Kunze","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11910-023-01260-8","article-title":"Parkinson\u2019s disease, parkinsonisms, and mitochondria: The role of nuclear and mitochondrial DNA.","volume":"23","author":"Legati","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1214677","article-title":"Inflammation in multiple system atrophy.","volume":"14","author":"Le\u0144ska-Mieciek","year":"2023","journal-title":"Front. Immunol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8740419","article-title":"Phosphorylated alpha-synuclein in red blood cells as a potential diagnostic biomarker for multiple system atrophy: A pilot study.","volume":"2020","author":"Li","year":"2020","journal-title":"Parkinsons Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1007\/s12035-021-02375-0","article-title":"Gut microbial metabolites in Parkinson\u2019s disease: Implications of mitochondrial dysfunction in the pathogenesis and treatment.","volume":"58","author":"Liang","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/ana.23568","article-title":"Somatic mitochondrial DNA mutations in early Parkinson and incidental lewy body disease.","volume":"71","author":"Lin","year":"2012","journal-title":"Ann. Neurol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00146-2","article-title":"Clinical application of circulating tumour DNA in colorectal cancer.","volume":"8","author":"Loft","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.mito.2018.07.008","article-title":"Cell-free mitochondrial DNA in progressive multiple sclerosis.","volume":"46","author":"Lowes","year":"2019","journal-title":"Mitochondrion"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00362-y","article-title":"Circulating cell-free mitochondrial DNA levels in Parkinson\u2019s disease are influenced by treatment.","volume":"15","author":"Lowes","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"B47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","article-title":"A DNA methylation atlas of normal human cell types.","volume":"613","author":"Loyfer","year":"2023","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141911","article-title":"Liquid biopsy in neurological diseases.","volume":"12","author":"Malhotra","year":"2023","journal-title":"Cells (Basel, Switzerland)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/1055-9965.EPI-05-0210","article-title":"Mitochondrial DNA content increase in response to cigarette smoking.","volume":"15","author":"Masayesva","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prevent."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1158\/2159-8290.CD-21-1252","article-title":"The origin of highly elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer.","volume":"13","author":"Mattox","year":"2023","journal-title":"Cancer Discov."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1038\/s41380-021-01188-w","article-title":"Association of inflammation with depression and anxiety: Evidence for symptom-specificity and potential causality from UK biobank and nesda cohorts.","volume":"26","author":"Milaneschi","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/jamaneurol.2016.1325","article-title":"Plasma coenzyme q10 levels in patients with multiple system atrophy.","volume":"73","author":"Mitsui","year":"2016","journal-title":"JAMA Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","article-title":"The role of mitochondria in neurodegenerative diseases: The lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease.","volume":"57","author":"Monzio","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease.","volume":"9","author":"Moss","year":"2018","journal-title":"Nat. Commun."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104495","article-title":"The unresolved role of mitochondrial DNA in Parkinson\u2019s disease: An overview of published studies, their limitations, and future prospects.","volume":"129","author":"M\u00fcller-Nedebock","year":"2019","journal-title":"Neurochem. Int."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32573-1","article-title":"The pathogenesis linked to coenzyme q10 insufficiency in IPSC-derived neurons from patients with multiple-system atrophy.","volume":"8","author":"Nakamoto","year":"2018","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3233\/JAD-220301","article-title":"Circulating cell-free genomic DNA is associated with an increased risk of dementia and with change in cognitive and physical function.","volume":"89","author":"Nidadavolu","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.5604\/12321966.1232774","article-title":"Motor assessment in Parkinson\u2018s disease.","volume":"24","author":"Opara","year":"2017","journal-title":"Ann. Agr. Env. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/15622975.2021.1938214","article-title":"Circulating cell-free mitochondrial DNA in brain health and disease: A systematic review and meta-analysis.","volume":"23","author":"Park","year":"2022","journal-title":"World J. Biol. Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676621","article-title":"Immune response in neurological pathology: Emerging role of central and peripheral immune crosstalk.","volume":"12","author":"Passaro","year":"2021","journal-title":"Front. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00401-023-02562-4","article-title":"Urinary tract infections trigger synucleinopathy via the innate immune response.","volume":"145","author":"Peelaerts","year":"2023","journal-title":"Acta Neuropathol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jalz.2013.04.508","article-title":"Mitochondrial DNA deletions in Alzheimer\u2019s brains: A review.","volume":"10","author":"Phillips","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1104732","article-title":"Comparison of the structures and topologies of plasma extracted circulating nuclear and mitochondrial cell-free DNA.","volume":"14","author":"Pisareva","year":"2023","journal-title":"Front. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2012.04.006","article-title":"The origin and properties of extracellular DNA: From pamp to damp.","volume":"144","author":"Pisetsky","year":"2012","journal-title":"Clinical immunology (Orlando, Fla.)"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176298","article-title":"Cerebrospinal fluid mitochondrial DNA in rapid and slow progressive forms of Alzheimer\u2019s disease.","volume":"21","author":"Podlesniy","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nbd.2016.05.019","article-title":"Mitochondrial DNA in csf distinguishes lrrk2 from idiopathic Parkinson\u2019s disease.","volume":"94","author":"Podlesniy","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","article-title":"Advances in markers of prodromal Parkinson disease.","volume":"12","author":"Postuma","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"Mds clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105885","article-title":"Cell-free mitochondrial DNA deletions in idiopathic, but not lrrk2, Parkinson\u2019s disease.","volume":"174","author":"Puigr\u00f2s","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neurobiolaging.2015.10.033","article-title":"Reduced mitochondrial DNA copy number is a biomarker of Parkinson\u2019s disease.","volume":"38","author":"Pyle","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ana.24515","article-title":"Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson\u2019s disease.","volume":"78","author":"Pyle","year":"2015","journal-title":"Ann. Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/s0968-0004(00)01674-1","article-title":"Mitochondria, oxygen free radicals, disease and ageing.","volume":"25","author":"Raha","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107830","article-title":"Senescence, necrosis, and apoptosis govern circulating cell-free DNA release kinetics.","volume":"31","author":"Rostami","year":"2020","journal-title":"Cell Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.nbd.2014.06.014","article-title":"Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in parkinson\u2019s disease.","volume":"70","author":"Sanders","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2009.01.031","article-title":"Quantitative plasma DNA analysis in Parkinson\u2019s disease.","volume":"452","author":"Scalzo","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(89)92366-0","article-title":"Mitochondrial complex i deficiency in Parkinson\u2019s disease.","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet (London, England)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149557","article-title":"Coenzyme q10 levels are decreased in the cerebellum of multiple-system atrophy patients.","volume":"11","author":"Schottlaender","year":"2016","journal-title":"PLoS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primary care: A case-control study.","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41551-021-00837-3","article-title":"Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.","volume":"6","author":"Song","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"B80","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: Comparison with the unified Parkinson\u2019s disease rating scale.","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"key":"B81","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.smim.2018.08.003","article-title":"Changes in the biochemical taste of cytoplasmic and cell-free DNA are major fuels for inflamm-aging.","volume":"40","author":"Storci","year":"2018","journal-title":"Semin. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"E5503","DOI":"10.1073\/pnas.1508736112","article-title":"Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.","volume":"112","author":"Sun","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B83","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","article-title":"Gut microbial ecosystem in Parkinson disease: New clinicobiological insights from multi-omics.","volume":"89","author":"Tan","year":"2021","journal-title":"Ann. Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson\u2019s disease.","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.mito.2021.04.002","article-title":"Stress and circulating cell-free mitochondrial DNA: A systematic review of human studies, physiological considerations, and technical recommendations.","volume":"59","author":"Trumpff","year":"2021","journal-title":"Mitochondrion"},{"key":"B86","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/hmg\/ddy009","article-title":"Genetic and clinical evidence of mitochondrial dysfunction in autism spectrum disorder and intellectual disability.","volume":"27","author":"Valiente-Pallej\u00e0","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"B87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mito.2016.12.003","article-title":"Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis.","volume":"34","author":"Varhaug","year":"2017","journal-title":"Mitochondrion"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052818","article-title":"Quantification of circulating cell-free DNA in idiopathic Parkinson\u2019s disease patients.","volume":"25","author":"Wojtkowska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/gerona\/glx033","article-title":"Interrelations between mitochondrial DNA copy number and inflammation in older adults.","volume":"72","author":"Wu","year":"2017","journal-title":"J. Gerontol. Ser. A-Biol. Sci. Med. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/mds.29674","article-title":"Peripheral inflammatory and immune landscape in multiple system atrophy: A cross-sectional study.","volume":"39","author":"Yuan","year":"2024","journal-title":"Mov. Disord."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1001\/jamapsychiatry.2024.2185","article-title":"Inflammatory biomarkers and risk of psychiatric disorders.","volume":"81","author":"Zeng","year":"2024","journal-title":"JAMA Psychiatry"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1488820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T06:24:27Z","timestamp":1733120667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2024.1488820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":91,"alternative-id":["10.3389\/fnins.2024.1488820"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2024.1488820","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2024.1488820.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2024.1488820.s002","asserted-by":"subject"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"article-number":"1488820"}}